✦ LIBER ✦

tBuCO-ψ[CO-N(OH)]-Gly-NHiPr

✍ Scribed by Aubry, A. ;Dupont, V. ;Marraud, M.

Book ID: 114511326
Publisher: International Union of Crystallography
Year: 1995
Tongue: English
Weight: 321 KB
Volume: 51
Category: Article
ISSN: 0108-2701
DOI: 10.1107/s0108270194006025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structure of tBuCO-Gly-Glyψ[CH2-N+H2]NHE

Structure of tBuCO-Gly-Glyψ[CH2-N+H2]NHEt.BPh4−

✍ El-Masdouri, L. ;Aubry, A. ;Grand, V. ;Marraud, M. 📂 Article 📅 1992 🏛 International Union of Crystallography 🌐 English ⚖ 327 KB

Structure of tBuCO-Valψ[NH-CO]NHtBu

✍ El-Masdouri, L. ;Aubry, A. ;Gomez, E. ;Vitoux, B. ;Marraud, M. 📂 Article 📅 1992 🏛 International Union of Crystallography 🌐 English ⚖ 208 KB

Turn induction by N-aminoproline Compari

Turn induction by N-aminoproline Comparison of the Gly-Pro-Gly and Glyψ[CO-NH-N]Pro-Gly sequences

✍ ZERKOUT, S. ;DUPONT, V. ;AUBRY, A. ;VIDAL, J. ;COLLET, A. ;VICHERAT, A. ;MARRAUD 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 711 KB

Conformational perturbations in retro-an

Conformational perturbations in retro-analogs of the tBuCO-Ala-Gly-NHiPr dipeptide Crystal structure of the retro-dipeptide with a reversed Ala-Gly amide bond

✍ GOMEZ, EMMANUEL J. ;VITOUX, BERNARD ;MARRAUD, MICHEL ;SAKARELLOS, CONSTANTINOS ; 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 466 KB

Structure of MeCO-Glyψ[NH-CO]NHMe

✍ El-Masdouri, L. ;Aubry, A. ;Gomez, E. ;Vitoux, B. ;Marraud, M. 📂 Article 📅 1992 🏛 International Union of Crystallography 🌐 English ⚖ 321 KB

Fluoroolefin dipeptide isosteres — I.: T

Fluoroolefin dipeptide isosteres — I.: The synthesis of Glyψ(CFCH)Gly and racemic Pheψy(CFCH)Gly

✍ Thomas Allmendinger; Pascal Furet; Ernst Hungerbühler 📂 Article 📅 1990 🏛 Elsevier Science 🌐 French ⚖ 255 KB

The syntheses of Gly-Gly and racemic Phe-Gly fluoroolefin dipeptide isosteres are described, the firs-f examples of a new class of peptkle anabgues. The use of non-hydrolyzable amide isosteres is an established approach 12 to overcoming one of the major drawbacks in the use of peptides as therapeut